A national program is working to improve how frontline healthcare workers recognize signs of cognitive decline.

Over seven million Americans currently have Alzheimer disease (AD). That’s according to the Alzheimer’s Association. One out of every nine seniors over 65 will experience some degree of dementia.

Researchers say they are now able to predict Alzheimer’s disease with close to 93 percent accuracy using artificial ...

What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 semaglutide for AD, about what the results mean — and what comes next ...

Each monthly installment examines an aspect of Alzheimer's disease care, including making and delivering the diagnosis; ...

Blood tests that detect a protein involved in Alzheimer’s disease could help predict the age at which the disease may strike people long before they develop symptoms, according to a new study. But ...

New paper from UC Santa Cruz chemistry lab argues that efforts to develop treatments for Alzheimer's should stop ignoring a short protein called P3, the ‘neglected cousin’ of amyloid beta ...

An estimated 3,100 people in Wolverhampton have been diagnosed with dementia.

In people destined to get Alzheimer's in their mid-40s, one protein can delay the onset of the disease by about 20 years.

A major study involving over 160,000 dementia patients has found that risperidone, a commonly prescribed antipsychotic drug, is associated with higher stroke risk across all dementia patient groups ...

Reviewed by Anton Porsteinsson, MD, Director of the University of Rochester Alzheimer’s Disease Care, Research and Education Program (AD-CARE) in New York; and the first William B. and Sheila Konar, ...

More than 7 million Americans currently have Alzheimer’s disease (AD). That’s according to the Alzheimer’s Association. One out of every nine seniors over age 65 will experience some degree of ...